Kiora Pharmaceuticals (KPRX) Current Assets (2014 - 2026)
Kiora Pharmaceuticals' (KPRX) quarterly Current Assets came in at $18.7 million in Q1 2026, down 31.08% YoY from $27.1 million in Q1 2025, and down 14.1% on a QoQ basis from $21.7 million in Q4 2025.
Kiora Pharmaceuticals (KPRX) Current Assets (2014 - 2026) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 13 years of Current Assets data on file, last reported at $18.7 million in Q1 2026.
- Quarterly Current Assets fell 31.08% year-over-year to $18.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.7 million (down 31.08% YoY) and the FY2025 annual result came in at $21.7 million, down 26.79% from the prior year.
- Current Assets declined to $18.7 million in Q1 2026, from $21.7 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $33.5 million in Q1 2024 to a low of $4.4 million in Q2 2022.
- A 5-year average of $17.2 million and a median of $18.7 million in 2026 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets slumped 44.19% — and 2024, when it soared 526.97%.
- Tracing KPRX's Current Assets over 5 years: stood at $7.7 million in 2022, then slumped by 38.31% to $4.7 million in 2023, then soared by 526.97% to $29.7 million in 2024, then declined by 26.79% to $21.7 million in 2025, then declined by 14.1% to $18.7 million in 2026.
- The last three Current Assets figures came in at $18.7 million (Q1 2026), $21.7 million (Q4 2025), and $22.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - | 1.76 Bn |
| 10 | Kiora Pharmaceuticals | 16.06 Mn | 16.06 Mn | - | 21.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.26 Mn |
| Mar 31, 2026 | 18.68 Mn |
| Dec 31, 2025 | 21.75 Mn |
| Sep 30, 2025 | 22.69 Mn |
| Jun 30, 2025 | 24.74 Mn |
| Mar 31, 2025 | 27.11 Mn |
| Dec 31, 2024 | 29.71 Mn |
| Sep 30, 2024 | 31.65 Mn |
| Jun 30, 2024 | 31.83 Mn |
| Mar 31, 2024 | 33.48 Mn |
| Dec 31, 2023 | 4.74 Mn |
| Sep 30, 2023 | 6.98 Mn |
| Jun 30, 2023 | 9.02 Mn |
| Mar 31, 2023 | 5.62 Mn |
| Dec 31, 2022 | 7.68 Mn |
| Sep 30, 2022 | 6.62 Mn |
| Jun 30, 2022 | 4.38 Mn |
| Mar 31, 2022 | 6.55 Mn |
| Dec 31, 2021 | 8.99 Mn |
| Sep 30, 2021 | 11.87 Mn |